GEN Exclusives

More »

GEN News Highlights

More »
Nov 27, 2007

Protein-Protein Interaction Involved in the Spread of Cancer Discovered

  • A team of researchers at the NCI uncovered a novel protein interaction in mice that promotes metastasis in sarcomas. 
    The scientists focused on post-translational modifications by examining the role of the protein gp78 in cancer. gp78 tags specific proteins with ubiquitin, which can lead to the destruction of the tagged proteins by the proteasome.

    By silencing the activity of gp78, the NCI team found that the spread and survival of cancer cells in animal models was greatly reduced. The researchers also discovered that gp78 interacts with another protein called KAI1, which has previously been shown to interfere with metastasis and is categorized as a metastasis suppressor.

    Further investigation showed that silencing gp78 in sarcoma cells caused levels of KAI1 to rise, thus decreasing cancer cell survival. Conversely, in sarcoma cells with high levels of gp78, KAI1 was more frequently tagged for destruction.

    The scientists found that this silencing of KAI1 in cancer cells encouraged both cancer cell survival and metastasis. Going a step further, the NCI team examined archived sarcoma tumor samples from patients and found that tumors with low levels of gp78 had higher levels of KAI1 and vice versa. 

    The findings will be published in the December issue of Nature Medicine and  is currently available online.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?